Published in Medical Patent Week, March 20th, 2005
The Japanese Patent Office, after 10 years of examining of the company's application, granted the patent innovation to Bio Holdings International, Ltd., the company's wholly owned subsidiary, under the patent number 3559568. The Patent will expire in 2017.
The JPO is officially part of the Ministry of Economy, Trade and Industry in Japan (METI) and contributes to the development of industry by securing and protecting the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.